Give Hope Blog

colorectal cancer screening

Certain colorectal patients may benefit from immunotherapy

September 16, 2019 | Zen Vuong

People with colon and rectal tumors prone to “immune overdrive” don’t do well if they concurrently have an immune-suppressive tumor microenvironment, City of Hope researchers say.

Continue Reading

Stacy Gray, M.D. - Profile Photo

Study finds most aren't upset by learning genetic test results

September 10, 2019 | Letisia Marquez

A National Institutes of Health-funded study led by City of Hope’s Stacy Gray, M.D., examined a person’s emotional state before they received test results and after. Researchers found that anxiety and depression did not increase significantly following genetic test result disclosure.

Continue Reading

Ajay Goel

A blood test for cancer? New department focuses on early detection

August 28, 2019 | Maxine Nunes

Dynamic and passionate — with a formidable track record of innovations in cancer care — Ajay Goel, Ph.D., M.S., has recently joined the staff at City of Hope, and he’s hit the ground running.

Continue Reading

rahul jandial headshot 256 x 256

Researcher receives $1.35M Department of Defense grant for breast metastasis study

August 20, 2019 | Michael Easterling

Rahul Jandial, M.D., Ph.D., has received the “Breakthrough” award from the Department of Defense's Breast Cancer Research Program to support his study of leptomeningeal disease, which is characterized by the spreading of tumor cells to the lining of the brain and spinal cord.

Continue Reading

HPV cells

Innovative approach using KITE-439 in targeting HPV-related malignancies

August 20, 2019 | City of Hope

HPV16-induced cancers, a strain that causes about 70% of all cervical cancers worldwide, are ideal candidates for targeted T cell therapy due to their nonself antigens.

Continue Reading

breakthroughs - liver cancer

ET140202 Artemis T Cell therapy for the treatment of liver cancer

August 20, 2019 | City of Hope

City of Hope is the first institution in the United States to open an immunotherapy clinical trial for liver cancer that eventually could transform treatment of the usually fatal disease into an outpatient procedure.

Continue Reading

Breakthroughs - prostate cancer clinical trial

PSCA as a novel CAR T target for resistant prostate cancer

August 20, 2019 | City of Hope

In this phase 1 trial, the safety and tolerability of autologous anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytes are studied in adult patients with PSCA+ metastatic castration-resistant prostate cancer.

Continue Reading

breast cancer screening

Cancer screening guidance from City of Hope experts

August 16, 2019 | Samantha Bonar

August 16 is National Cancer Screening Day for breast, cervical and colorectal cancer. The day is an effort to increase awareness and education for breast, cervical and colorectal cancers.

Continue Reading

Back To Top